GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.170
-0.625 (-22.36%)
At close: Jul 7, 2025, 4:00 PM
2.150
-0.020 (-0.92%)
After-hours: Jul 7, 2025, 7:50 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $6.83 million as of July 7, 2025. Its market cap has increased by 8.48% in one year.
Market Cap
6.83M
Enterprise Value
4.47M
1-Year Change
8.48%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $6.83M, a decrease of -99.27%. That is a compound annual growth rate of -11.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 700.84B |
| Johnson & Johnson | 375.37B |
| AbbVie | 334.34B |
| Novo Nordisk | 316.33B |
| UnitedHealth Group | 279.90B |
| Novartis AG | 242.35B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 218.65B |